Alkermes plc. Increase (Decrease) in Contract with Customer, Liability
Alkermes plc. (ALKS) reported Increase (Decrease) in Contract with Customer, Liability of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-07-28
- Alkermes plc. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was $0.00.
- Alkermes plc. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was -$578.00K.
- Alkermes plc. increase (decrease) in contract with customer, liability for the quarter ending 2025-06-30 was -$1.03M.
- Alkermes plc. increase (decrease) in contract with customer, liability for the quarter ending 2025-03-31 was $359.00K.
- Alkermes plc. increase (decrease) in contract with customer, liability for fiscal 2025 was -$1.25M.
- Alkermes plc. increase (decrease) in contract with customer, liability for fiscal 2024 was -$3.52M.
- Alkermes plc. increase (decrease) in contract with customer, liability for fiscal 2023 was -$5.93M.
- Alkermes plc. increase (decrease) in contract with customer, liability for fiscal 2022 was -$7.13M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-28 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$578.00K derived: sum of 2 quarters · filed 2026-02-25 | -$1.61M derived: sum of 3 quarters · filed 2026-07-28 | -$1.25M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$578.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$1.61M derived: sum of 2 quarters · filed 2026-07-28 | -$1.25M 10-Q · filed 2025-10-28 | -$2.34M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | -$671.00K 10-Q · filed 2026-07-28 | -$1.76M derived: sum of 3 quarters · filed 2026-07-28 | -$2.73M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $359.00K 10-Q · filed 2026-05-05 | -$731.00K derived: sum of 2 quarters · filed 2026-05-05 | -$1.70M derived: sum of 3 quarters · filed 2026-05-05 | -$2.96M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$2.06M derived: sum of 2 quarters · filed 2026-02-25 | -$3.32M derived: sum of 3 quarters · filed 2026-02-25 | -$3.52M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$972.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$2.23M derived: sum of 2 quarters · filed 2025-10-28 | -$2.44M 10-Q · filed 2025-10-28 | -$2.64M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$1.46M 10-Q · filed 2025-07-29 | -$1.67M derived: sum of 3 quarters · filed 2026-02-25 | -$2.36M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$208.00K 10-Q · filed 2025-05-01 | -$410.00K derived: sum of 2 quarters · filed 2026-02-25 | -$1.10M derived: sum of 3 quarters · filed 2026-02-25 | -$1.85M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$202.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$894.00K derived: sum of 2 quarters · filed 2026-02-25 | -$1.64M derived: sum of 3 quarters · filed 2026-02-25 | -$5.93M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$692.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | -$1.44M derived: sum of 2 quarters · filed 2024-10-24 | -$5.72M 10-Q · filed 2024-10-24 | -$3.66M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | -$745.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-24 | -$5.03M 10-Q · filed 2024-07-24 | -$2.97M derived: sum of 3 quarters · filed 2025-02-12 | -$8.09M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | -$4.29M 10-Q · filed 2024-05-01 | -$2.23M derived: sum of 2 quarters · filed 2025-02-12 | -$7.34M derived: sum of 3 quarters · filed 2025-02-12 | -$8.44M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$3.06M derived: sum of 2 quarters · filed 2025-02-12 | -$4.15M derived: sum of 3 quarters · filed 2025-02-12 | -$7.13M 10-K · filed 2025-02-12 |
| 2022-09-30 | -$5.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | -$6.21M derived: sum of 2 quarters · filed 2023-10-25 | -$9.19M 10-Q · filed 2023-10-25 | -$10.63M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | -$1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | -$4.07M 10-Q · filed 2023-07-26 | -$5.51M derived: sum of 3 quarters · filed 2024-02-21 | -$7.04M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | -$2.98M 10-Q · filed 2023-04-26 | -$4.42M derived: sum of 2 quarters · filed 2024-02-21 | -$5.95M derived: sum of 3 quarters · filed 2024-02-21 | -$7.82M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$2.97M derived: sum of 2 quarters · filed 2024-02-21 | -$4.84M derived: sum of 3 quarters · filed 2024-02-21 | -$6.08M 10-K · filed 2024-02-21 |
| 2021-09-30 | -$1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$3.40M derived: sum of 2 quarters · filed 2022-11-02 | -$4.64M 10-Q · filed 2022-11-02 | -$6.52M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | -$1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | -$3.11M 10-Q · filed 2022-07-27 | -$4.99M derived: sum of 3 quarters · filed 2023-02-16 | -$5.67M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | -$1.24M 10-Q · filed 2022-04-27 | -$3.12M derived: sum of 2 quarters · filed 2023-02-16 | -$3.80M derived: sum of 3 quarters · filed 2023-02-16 | -$5.31M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | -$1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$2.56M derived: sum of 2 quarters · filed 2023-02-16 | -$4.07M derived: sum of 3 quarters · filed 2023-02-16 | -$4.92M 10-K · filed 2023-02-16 |
| 2020-09-30 | -$681.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | -$2.19M derived: sum of 2 quarters · filed 2021-10-27 | -$3.04M 10-Q · filed 2021-10-27 | $12.80M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | -$1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$2.36M 10-Q · filed 2021-07-28 | $13.48M derived: sum of 3 quarters · filed 2022-02-16 | $12.75M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | -$859.00K 10-Q · filed 2021-04-28 | $14.99M derived: sum of 2 quarters · filed 2022-02-16 | $14.25M derived: sum of 3 quarters · filed 2022-02-16 | $14.56M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $15.85M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $15.11M derived: sum of 2 quarters · filed 2022-02-16 | $15.41M derived: sum of 3 quarters · filed 2022-02-16 | $16.14M 10-K · filed 2022-02-16 |
| 2019-09-30 | -$738.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$433.00K derived: sum of 2 quarters · filed 2020-10-29 | $292.00K 10-Q · filed 2020-10-29 | $1.06M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $305.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $1.03M 10-Q · filed 2020-07-29 | $1.80M derived: sum of 3 quarters · filed 2021-02-11 | $2.94M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $725.00K 10-Q · filed 2020-04-29 | $1.49M derived: sum of 2 quarters · filed 2021-02-11 | $2.63M derived: sum of 3 quarters · filed 2021-02-11 | $3.73M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $767.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $1.91M derived: sum of 2 quarters · filed 2021-02-11 | $3.01M derived: sum of 3 quarters · filed 2021-02-11 | $3.25M 10-K · filed 2021-02-11 |
| 2018-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23 | $2.24M derived: sum of 2 quarters · filed 2019-10-23 | $2.48M 10-Q · filed 2019-10-23 | $2.14M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $1.34M 10-Q · filed 2019-07-25 | $998.00K derived: sum of 3 quarters · filed 2020-02-13 | $369.00K derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $245.00K 10-Q · filed 2019-04-25 | -$100.00K derived: sum of 2 quarters · filed 2020-02-13 | -$729.00K derived: sum of 3 quarters · filed 2020-02-13 | |
| 2017-12-31 | -$345.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$974.00K derived: sum of 2 quarters · filed 2020-02-13 | -$1.45M 10-K · filed 2020-02-13 | |
| 2017-09-30 | -$629.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | -$1.10M 10-Q · filed 2018-10-23 | ||
| 2017-06-30 | -$473.00K 10-Q · filed 2018-07-26 | |||
| 2016-12-31 | -$649.00K 10-K · filed 2019-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |